A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study-Reference-Cited by-同舟云学术

A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study

Published:2022-11-05 Issue:12 Volume:129 Page:1513-1526
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J Neural Transm

Author:

Yilmaz Niyazi Samet^ORCID,Sen Bayram,Karadag Rukiye Filiz,Aslan Selcuk,Ekmekci Ertek Irem,Bozkurt Aruz,Cicek Saba,Bolu Abdullah,Ucar Huseyin,Kocak Cemal,Cevik Cemal,Bukan Neslihan

Funder

Gazi Üniversitesi

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00702-022-02553-x.pdf

Reference88 articles.

1. Aarsland TI, Leskauskaite I, Midttun Ø, Ulvik A, Ueland PM, Oltedal L, Erchinger VJ, Oedegaard KJ, Haavik J, Kessler U (2019) The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites. Brain Stimul 12(5):1135–1142

2. Adu MK, Shalaby R, Chue P, Agyapong VI (2022) Repetitive transcranial magnetic stimulation for the treatment of resistant depression: a scoping Review. Behav Sci 12(6):195

3. Allen AP, Naughton M, Dowling J, Walsh A, O’Shea R, Shorten G, Scott L, McLoughlin D, Cryan JF, Clarke G (2018) Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: comparison of multiple ketamine infusions and electroconvulsive therapy. J Psychiatr Res 100:24–32